chrX-1309528-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000381529.9(CSF2RA):c.*49G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0121 in 1,613,780 control chromosomes in the GnomAD database, including 195 homozygotes. There are 10,195 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0091 ( 9 hom., 703 hem., cov: 33)
Exomes 𝑓: 0.012 ( 186 hom. 9492 hem. )
Consequence
CSF2RA
ENST00000381529.9 3_prime_UTR
ENST00000381529.9 3_prime_UTR
Scores
1
10
Clinical Significance
Conservation
PhyloP100: -0.816
Genes affected
CSF2RA (HGNC:2435): (colony stimulating factor 2 receptor subunit alpha) The protein encoded by this gene is the alpha subunit of the heterodimeric receptor for colony stimulating factor 2, a cytokine which controls the production, differentiation, and function of granulocytes and macrophages. The encoded protein is a member of the cytokine family of receptors. This gene is found in the pseudoautosomal region (PAR) of the X and Y chromosomes. Multiple transcript variants encoding different isoforms have been found for this gene, with some of the isoforms being membrane-bound and others being soluble. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0028986335).
BP6
Variant X-1309528-G-A is Benign according to our data. Variant chrX-1309528-G-A is described in ClinVar as [Benign]. Clinvar id is 3036043.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00915 (1392/152192) while in subpopulation SAS AF= 0.0324 (156/4822). AF 95% confidence interval is 0.0282. There are 9 homozygotes in gnomad4. There are 703 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF2RA | NM_172245.4 | c.*49G>A | 3_prime_UTR_variant | 13/13 | ENST00000381529.9 | NP_758448.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF2RA | ENST00000381529.9 | c.*49G>A | 3_prime_UTR_variant | 13/13 | 1 | NM_172245.4 | ENSP00000370940 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00916 AC: 1393AN: 152074Hom.: 9 Cov.: 33 AF XY: 0.00946 AC XY: 703AN XY: 74292
GnomAD3 genomes
AF:
AC:
1393
AN:
152074
Hom.:
Cov.:
33
AF XY:
AC XY:
703
AN XY:
74292
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0116 AC: 2901AN: 251160Hom.: 36 AF XY: 0.0131 AC XY: 1778AN XY: 135722
GnomAD3 exomes
AF:
AC:
2901
AN:
251160
Hom.:
AF XY:
AC XY:
1778
AN XY:
135722
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0124 AC: 18193AN: 1461588Hom.: 186 Cov.: 33 AF XY: 0.0131 AC XY: 9492AN XY: 727078
GnomAD4 exome
AF:
AC:
18193
AN:
1461588
Hom.:
Cov.:
33
AF XY:
AC XY:
9492
AN XY:
727078
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00915 AC: 1392AN: 152192Hom.: 9 Cov.: 33 AF XY: 0.00945 AC XY: 703AN XY: 74420
GnomAD4 genome
AF:
AC:
1392
AN:
152192
Hom.:
Cov.:
33
AF XY:
AC XY:
703
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
TwinsUK
AF:
AC:
57
ALSPAC
AF:
AC:
52
ExAC
AF:
AC:
1475
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 01, 2022 | p.Arg358Gln in exon 11 of CSF2RA: This variant is not expected to have clinical significance because it has been identified in 3% (927/30780) of South Asian chromosomes, including 17 homozygotes and 1.2% (1538/128868) of European chromosomes, including 13 homozygotes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1; BP4. - |
CSF2RA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N;N;N;N;N;N;N
PROVEAN
Benign
N
REVEL
Benign
Sift
Pathogenic
D
Vest4
ClinPred
T
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at